The U3-U7 gene cluster of human herpesvirus 6 (HHV-6) was replaced with an enhanced green fluorescent protein-puromycin gene cassette containing the cytomegalovirus major immediate-early promoter. Neither viral replication in T cells nor latency and reactivation in macrophages was impaired. During HHV-6 latency, the cytomegalovirus promoter used the transcription start sites employed in cytomegalovirus latency.
Human herpesvirus 6 (HHV-6) normally produces relatively mild diseases (2, 3, 5, 7, 10) , and thus it has been suggested as a viral vector candidate for gene therapy (36) . However, the establishment of a recombinant HHV-6 is difficult and has not been reported. The difficulty is partly due to a technical issue that we describe below. It is also due to the nature of the HHV-6 genome. Many HHV-6 genes are homologous to those of human cytomegalovirus (HCMV); however, HHV-6 has a smaller number of genes than HCMV, and it does not encode homologues of the HCMV genes that are dispensable for viral replication and are deleted in making recombinant HCMV (9, 12, 14, 26) . To make a recombinant virus by homologous recombination, a dispensable gene(s) that can be replaced with a drug-resistant gene needs to be found.
To identify genes that are dispensable for viral replication, we replaced a gene cluster of the HHV-6 genome with EGFPpuro, a gene cassette containing the gene for enhanced green fluorescent protein (EGFP) under control of the HCMV major FIG. 1. Structure of H6R28. At the top is a map of the HHV-6B HST genome, with the region U1 to U9 expanded below. In the middle, shaded arrows show the U3-U7 open reading frames (coordinates 10315 to 16302) that were replaced by the EGFP-puro cassette. The locations of the PCR primers used for the cloning of the U2 and U8 DNA fragments (U2 XbaI, U2 AflII, U8 BamHI, and U8 EcoRI) and the primers for the verification of the recombinant virus are depicted. Primer sequences are shown in Table 1 . The bottom diagram represents the EGFP-puro cassette pU2-U8 EGFP-puro. The open box represents the EGFP gene and HCMV MIEP that was derived from pEGFP-C1 (nucleotide numbers 8 to 1640) (Clontech). Multiple cloning sites of pEGFP-C1 including PstI were deleted. The puromycin-N-acetyl-transferase gene (pac) and SV40 early promoter were derived from pPUR (nucleotide numbers Ϫ408 to 1392) (Clontech). The annealing sites of the primers used are depicted by small solid arrows. The recognition sites of the restriction enzymes used (PstI, AflII, and BamHI) are also shown. The sizes of the amplified or digested products are indicated by dotted arrows.
immediate-early enhancer-promoter (MIEP) and the puromycin resistance gene under control of the simian virus 40 (SV40) early promoter (Fig. 1) . To insert the EGFP-puro cassette into the HHV-6 genome by homologous recombination, 1-kb segments of viral genome were inserted into each end of the cassette (Fig. 1) . The following gene clusters were examined: the DR2-DR7 genes, which are duplicated in the viral genome (9, 12, 14) ; U95, the positional homologue of the murine cytomegalovirus (MCMV) immediate-early (IE) 2 gene, which is known to be dispensable for viral replication (4); and the U3-U7 genes. Of these, we found that replacement of the U3-U7 genes with EGFP-puro resulted in a successfully replicating virus.
For the construct, the U2 gene was amplified by PCR with primers U2 XbaI and U2 AflII, and the U8 gene was amplified with U8 BamHI and U8 EcoRI (primers used in this study are listed in Table 1 ). The amplified products were then inserted into each end of pEGFP-puro (pU2-U8 EGFP-puro in Fig. 1 ). The cloned plasmid was transfected into phytohemagglutinin (PHA)-stimulated peripheral blood mononuclear cells by us- 3) and H6R28 (lanes 2, 4, 5, and 6) was amplified with double-nested PCR using primer pairs U2R2-U8F2 and U2R1-U8F1. The amplified products were digested with PstI (lanes 3 and 4), AflII (lane 5), or BamHI (lane 6). The undigested products were separated on a 0.6% agarose gel (lanes 1 and 2), and the digested ones were separated on a 1.0% gel (lanes 3 to 6). The expected sizes of the digested products from the wt virus are shown by open arrows, and the expected products from H6R28 are depicted with solid arrows. The positions of the products are depicted in Fig. 1. (B) DNA from H6R28 was amplified by PCR with primers U2R1-EGFPprim (lane 1) or U8F1-PACprim (lane 2). The amplified products were separated on a 1.0% agarose gel. The expected sizes of the products (1,582 bp for U2R1-EGFPprim and 1,760 bp for PACprim-U8R1) are depicted by arrows. (C) PCR amplification of the deleted open reading frames. Viral DNA from wt virus (lanes 1 to 5) and H6R28 (lanes 6 to 10) was amplified by PCR using primer pairs U3F1-U3R1 (lanes 1 and 6), U4F1-U4R1 (lanes 2 and 7), U5F1-U5R1 (lanes 3 and 8), U6F1-U6R1 (lanes 4 and 9), or U7F1-U7R1 (lanes 5 and 10). The amplified products were separated on a 1.0% agarose gel. The expected sizes of the products, indicated by arrows, are as follows: U3F-U3R, 1,161 bp; U4F-U4R, 1,338 bp; U5F-U5R, 1,275 bp; U6F-U6R, 171 bp; U7F-U7R, 1,094 bp. Lanes M, 1-kbp ladder Plus (Invitrogen).
ing a Nucleofector electroporator (Amaxa Biosystems, Germany) according to the manufacturer's recommended protocol. Briefly, 5 ϫ 10 6 cells were mixed with 5 g of the plasmid and 100 l of Nucleofector solution for T cells, and electroporation was performed with the Nucleofector using the program U-14. Alternatively, a conventional electroporation method was used. In this case, 1 ϫ 10 7 cells were mixed with 50 g of the plasmid suspended in 500 l of K-phosphate-buffered saline (30.8 mM NaCl, 120.7 mM KCl, 8.1 mM Na 2 HPO 4 , 1.46 mM KH 2 PO 4 , and 25 mM MgCl 2 ), and the mixture was placed in an electroporation cuvette (Gene Pulser cuvette, 0.4-cm diameter; Bio-Rad). Electroporation was performed with a Gene Pulser II electroporation system (Bio-Rad) with resistance at infinity, voltage at 300 V, and capacitance at 960 F. After 6 h, the cells were infected with HHV-6 variant B of the HST strain at a multiplicity of infection (MOI) of 0.5 using the centrifuge method (37) .
Cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum for 3 days and frozen as a virus stock. To enrich for the recombinant virus, PHA-stimulated umbilical cord blood mononuclear cells (CBMCs) were infected with the virus stock and cultured for 1 day, treated with 7.5 ng of puromycin/ml for 1 day, washed with the medium, and cultured with CBMCs for 3 days. The infected cells were then frozen as a new virus stock. This selection procedure was repeated five times, and the recombinant virus (H6R28) was subsequently cloned by limiting dilution using CBMCs cultured in 96-well plates. Informed consent was obtained from the blood donors for participation in the study.
To confirm the insertion of the EGFP-puro cassette into the expected region, viral DNA was amplified by double-nested PCR with KOD Plus DNA polymerase (TOYOBO, Otsu, Japan) using primers against regions outside the homologous hinge regions (U2R2-U8F2 and U2R1-U8F1) (Fig. 1 ). An amplified product of approximately 8.5 kb was observed in the wild-type (wt) virus, and 5.0-kb bands were observed in three clones of H6R28 (representative cases are shown in Fig. 2A ). The amplified products were digested with the restriction enzymes shown in Fig. 1 , giving rise to the expected bands in both wt virus and H6R28 ( Fig. 2A) . The amplified products were confirmed by partial sequencing (data not shown). The 8.5-kb product was not observed in the recombinants, which indicated that they were not contaminated with the wt virus. The inserted position of EGFP-puro was also examined using primers ho- 
a Primers used for PCR. The annealing sites and the directions of the primers are shown in Fig. 1 mologous to EGFP-puro, and the expected PCR products were observed (Fig. 2B) . To address the possibility of the ectopic expression of U3-U7 genes, we attempted to amplify each gene from H6R28 by PCR, and no amplified products were obtained (Fig. 2C) . We produced three independent isolates of H6R28 by three individual electroporations and examined the replication kinetics in CBMCs. Virus titration was performed using CBMCs as described previously (1). CBMCs were infected at a MOI of 0.05, and the three H6R28 clones and the wt virus showed similar levels of viral spreading (Fig. 3A) and virus production (Fig. 3B ) over time.
We next investigated H6R28 for its ability to establish latency and its efficiency of reactivation. To evaluate the establishment of latency, peripheral blood macrophages were infected with wt virus and H6R28 and the percentage of HHV-6 DNA-positive cells was monitored as described previously (17, 19, 20) . Briefly, peripheral blood macrophages were cultured in RPMI 1640 supplemented with 25% horse serum on plastic plates coated with collagen (Sumitomo Bakelite Co., Ltd. Japan). The macrophages were infected with HHV-6 on day 7 and cultured for 4 to 6 weeks. The infected macrophages were detached from the plates, and the absence of viral replication was confirmed by immunofluorescent antibody (IFA) staining using monoclonal antibodies against glycoproteins B and H (29) . The cells were serially diluted (104 to 1 cell per tube) into sample tubes using four tubes for each dilution, and the DNA was isolated from each sample tube. Viral DNA was detected by double-nested PCR (18) , and the numbers of HHV-6 DNApositive cells were calculated by the Reed-Muench method (30) . This experiment showed similar percentages of HHV-6 DNA-positive cells in the wt virus-and H6R28-infected cultures (Fig. 4A) .
To study the reactivation efficiency, viral reactivation was induced by tetradecanoyl phorbol acetate (TPA) treatment as described previously (17, 20) . Briefly, latently infected cells were detached from the culture dish, serially diluted, and cocultivated with an uninfected macrophage feeder layer. Subsequently, the cells were treated with TPA (20 ng/ml) for 7 days and cocultivated with CBMCs for 7 days. The efficiency of the viral reactivation was calculated by the Reed-Muench method (30) and found to be similar for the wt virus and H6R28 (Fig. 4B) . From these data, we concluded that the establishment of latency and the reactivation process was not impaired by the deletion of the U3-U7 genes.
Interestingly, during HHV-6 latency, we failed to detect the expression of EGFP that was driven by the HCMV MIEP (25, 35) (Fig. 5A) . On the other hand, EGFP expression was observed in the latently infected macrophage transfected with the plasmid pU2-U8 EGFP-puro illustrated in Fig. 1 (Fig. 5B) , reactivation-induced macrophages (Fig. 5C) , productively infected CBMCs and Molt-3 cells (Fig. 5D and E) , and abortively Fig. 1 (transfection was performed as described previously [19] ). (C) Reactivation-induced macrophages that were treated with 20 ng of TPA/ml for 7 days (17, 19) . infected HeLa cells (Fig. 5F ). To investigate the gene expression from the IE1/IE2 promoter, 5Ј-rapid amplification of cDNA ends (RACE) was performed as described previously (19) (20) (21) . Briefly, the 5Ј end of the cDNA was dA tailed and annealed with an anchor primer, RL-1. The initial 10 cycles of PCR were performed with Taq polymerase (Roche Diagnostics) using the following conditions: denaturation for 1 min at 94°C, annealing for 1 min at 55°C, and extension for 1 min at 72°C. PCR amplification was performed with PCR with KOD Plus DNA polymerase (TOYOBO) using primers N2 and EGFP-R2 followed by primers N1 and EGFP-R1 (Fig. 6A) under the following conditions: denaturation for 1 min at 94°C, annealing for 30 s at 65°C, and extension for 1 min at 68°C (15 cycles per amplification). The amplified products were sequenced. In the latent cells, transcription of the mRNA from the usual transcription start position (productive infection transcription start site [PSS]) was not detected (Fig. 6B) ; however, small amounts of mRNA were transcribed from the latent infection transcription start sites (LSSs) 1 and 2 of HCMV, which are used to express the latency-associated transcripts of HCMV (21) . In contrast, the PSS was used in the latently infected macrophage transfected with the plasmid pU2-U8 EGFP-puro, reactivation-induced macrophages, and the productively infected Molt-3 cells and the abortively infected HeLa cells (Fig. 6B) . Since HCMV MIEP showed the latency-associated performance in the context of HHV-6 latency, it is suggested that the transcriptional control of HHV-6 latency may share some common mechanism with HCMV latency. These findings may be related to the fact that HCMV shows some similarity with HHV-6, such as the site of latency (8, 15-17, 24, 33, 34) .
Overall, the recombinant virus H6R28 revealed that the fairly large gene cluster U3-U7 was dispensable for viral replication, latency, and reactivation. Of the deleted genes, the characteristics of U4 and U6 have not been reported. Genes U3, U5, and U7 belong to the US22 gene family (9, 12, 28) , whose members are related to the HCMV US22 gene (6) . Every betaherpesvirus encodes several US22 family genes that encode at least one of four conserved motifs (28) . Although the functions of most of the US22 family genes are unknown, some of them, such as the MCMV IE2 gene and the HCMV UL36-38 genes, encode proteins with transactivating functions. However, MCMV IE2 is known to be dispensable for viral replication and latency and reactivation (4) . Deletion of the US22 family genes of H6R28 showed them to have similar properties; HHV-6 U3 encodes a protein with a weak transactivating function (27) , and we failed to find any difference in the viral replication or latency and reactivation between the wt and recombinant virus. The US22 family genes UL36 and UL37 of HCMV have an antiapoptotic function (11, 22, 31) . However, we did not observe increased apoptosis in H6R28-infected cells in the present study. Other US22 family genes, such as the MCMV M140 and M141 genes, confer altered cell and tissue tropism (13) . Since the in vivo host tissue range of HHV-6 is broad and since the virus infects various types of cells (2, 3) , it is possible that the HHV-6 US22 family genes contribute to the broad organ tropism of this virus.
H6R28 appears to be a useful tool for the study of HHV-6 latency and reactivation. Moreover, this large dispensable locus can be a useful site for inserting a large gene, such as a bacterial artificial chromosome vector (23, 32) .
We believe this is the first report of a successful recombinant HHV-6, and we can provide HHV-6 investigators with a detailed protocol for making it.
We give special thanks to Ed Mocarski for his kind advice on how to make recombinant herpesviruses.
This study was partially supported by a Special Coordination Fund and a grant-in-aid for general scientific research of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government. 5) was analyzed by the 5Ј-RACE method. The RACE method used was the same as that used in previous studies (19) (20) (21) . The 5Ј end of the transcript was dA tailed and annealed with the anchor primer RL-1 (Fig. 6A ) and amplified first with primers N2-EGFP R2 and then with primers N1-EGFP R1. The 5Ј ends of the transcript initiating at PSS (ϳ360 bp), LSS1 (ϳ720 bp), and/or LSS2 (ϳ650 bp) were detected. HaeIII-digested X174 DNA fragments were used as size markers (lane X).
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